Search results
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoUsually, RSV causes coldlike symptoms in most people. But in newborns and older adults it can be...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 7 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Miami· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Los Angeles· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 6 days agoParticipants in the older group received either the new shot alone or Moderna's old COVID-19...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 7 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 6 days agoThe second group included adults aged 50 to 64 and included use of the flu jab Fluarix. Dr Philip...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks· 3 days agoAn FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.
Feeling rough after your COVID shot? That's a sign it's working
Medical Xpress· 6 days agoThe study, which appears online June 10 in Annals of Internal Medicine, is based on symptom reports and antibody responses from 363 people, who had the Pfizer-BioNTech or ...